You are here

Clinical Trials: Cardiovascular Diseases

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Monday, January 1, 2018 - 12:00
Condition:   Heart Failure, Systolic
Interventions:   Drug: ITI-214;   Other: Placebo
Sponsor:   Intra-Cellular Therapies, Inc.
Not yet recruiting
Posted: Wednesday, December 27, 2017 - 12:00
Condition:   Cerebrovascular Disorders
Intervention:   Biological: exosome
Sponsor:   Isfahan University of Medical Sciences
Not yet recruiting
Posted: Wednesday, December 13, 2017 - 12:00
Condition:   Diabetic Foot Ulcer
Interventions:   Biological: ALLO-ASC-DFU;   Procedure: Vehicle sheet
Sponsor:   Anterogen Co., Ltd.
Not yet recruiting
Posted: Wednesday, December 13, 2017 - 12:00
Conditions:   Hemorrhagic Stroke;   Intracerebral Hemorrhage
Intervention:   Biological: MSC
Sponsor:   Mayo Clinic
Recruiting
Posted: Wednesday, December 6, 2017 - 12:00
Condition:   Pseudoxanthoma Elasticum
Intervention:   Other: urine collection
Sponsors:   University Hospital, Angers;   Université de Nantes;   Hungarian Academy of Sciences
Not yet recruiting
Posted: Wednesday, November 22, 2017 - 12:00
Conditions:   Chronic Heart Failure;   Old Myocardial Infarction
Intervention:   Biological: Stem cells administered to participants
Sponsors:   Sakakibara Heart Institute;   CellBank of Japan
Not yet recruiting
Posted: Friday, November 10, 2017 - 12:00
Condition:   Peripheral Arterial Occlusive Disease
Interventions:   Biological: allo-APZ2-PAOD;   Drug: Placebo
Sponsors:   RHEACELL GmbH & Co. KG;   FGK Clinical Research GmbH;   TICEBA GmbH;   Granzer Regulatory Consulting & Services
Not yet recruiting
Posted: Thursday, October 19, 2017 - 12:00
Condition:   Antioxidant Intervention
Interventions:   Dietary Supplement: L-carnosine;   Other: placebo
Sponsor:   University of Louisville
Not yet recruiting
Posted: Friday, October 13, 2017 - 12:00
Condition:   Cardiovascular Diseases
Interventions:   Behavioral: Health360x;   Behavioral: Health Coach
Sponsors:   Emory University;   American Heart Association
Recruiting
Posted: Monday, October 9, 2017 - 12:00
Condition:   Peripheral Artery Disease (PAD)
Interventions:   Drug: GM-CSF;   Drug: Placebo
Sponsors:   Emory University;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting

Pages